Location: Boston, MA
CIK: 0001595855 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $1.104B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IMMX | IMMIX BIOPHARMA INC | 2,345,000 | $24.18M | 2.2% | — | — | COM | 45258H106 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 745,000 | $18.03M | 1.6% | — | — | COM | 61225M102 |
| REPL | REPLIMUNE GROUP INC | 1,384,993 | $15.33M | 1.4% | — | — | COM | 76029N106 |
| VSTM | VERASTEM INC | 1,800,000 | $6.876M | 0.6% | — | — | COM NEW | 92337C203 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 185,589 | $2.014M | 0.2% | — | — | COM | 71722W107 |
| INBX | INHIBRX BIOSCIENCES INC | 20,291 | $1.923M | 0.2% | — | — | COM | 45720N103 |
| COAG | HEMAB THERAPEUTICS HLDGS INC | 47,652 | $1.75M | 0.2% | — | — | COM SHS | 423494103 |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS | 65,000 | $1.308M | 0.1% | — | — | ORD SHS | 337185102 |
| BHVN | BIOHAVEN LTD | 77,915 | $1.159M | 0.1% | — | — | COM | G1110E107 |
| KTTA | PASITHEA THERAPEUTICS CORP | 2,050,000 | $1.057M | 0.1% | — | — | COM NEW | 70261F202 |
| ADCT | ADC THERAPEUTICS SA | 700,000 | $749K | 0.1% | — | — | SHS | H0036K147 |
| OKYO | OKYO PHARMA LTD | 375,204 | $563K | 0.1% | — | — | SHS NEW | G6724L116 |
| PTN | PALATIN TECHNOLOGIES INC | 20,500 | $221K | 0.0% | — | — | COM NEW | 696077601 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IRON | DISC MEDICINE INC | 855,000 (+103.1%) | $62.53M (+132.3%) | 5.7% | — | — | COM | 254604101 |
| MGTX | MEIRAGTX HLDGS PLC | 3,550,000 (+67.2%) | $47.96M (+160.8%) | 4.3% | — | — | COM | G59665102 |
| CABA | CABALETTA BIO INC | 3,863,800 (+180.0%) | $12.02M (+223.7%) | 1.1% | — | — | COM | 12674W109 |
| EDIT | EDITAS MEDICINE INC | 3,861,930 (+100.4%) | $12.51M (+162.9%) | 1.1% | — | — | COM | 28106W103 |
| ACOG | ALPHA COGNITION INC | 2,895,467 (+13.0%) | $20.91M (+48.6%) | 1.9% | — | — | COM NEW | 02074J501 |
| XOMA | XOMA ROYALTY CORPORATION | 338,374 (+12.8%) | $14.38M (+52.8%) | 1.3% | — | — | COM NEW | 98419J206 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 700,000 (+1213.8%) | $5.334M (+1018.5%) | 0.5% | — | — | COM NEW | 107924102 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 334,437 (+197.8%) | $4.448M (+325.5%) | 0.4% | — | — | COM | 35104E100 |
| LYEL | LYELL IMMUNOPHARMA INC | 344,025 (+334.9%) | $4.834M (+204.6%) | 0.4% | — | — | COM NEW | 55083R203 |
| NTLA | INTELLIA THERAPEUTICS INC | 250,000 (+2.0%) | $4.23M (+34.7%) | 0.4% | — | — | COM | 45826J105 |
| VYGR | VOYAGER THERAPEUTICS INC | 1,185,000 (+3.0%) | $4.147M (-6.6%) | 0.4% | — | — | COM | 92915B106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,000,000 (+4.7%) | $3.42M (+0.0%) | 0.3% | — | — | COM | 77313F106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CATX | PERSPECTIVE THERAPEUTICS INC | 4,675,000 | $19.49M | 1.8% | — | — | — | 46489V302 |
| ASRT | ASSERTIO HOLDINGS INC | 265,707 | $5.064M | 0.5% | — | — | — | 04546C304 |
| STRO | SUTRO BIOPHARMA INC | 190,671 | $4.75M | 0.4% | — | — | — | 869367201 |
| TECX | TECTONIC THERAPEUTIC INC | 123,000 | $3.802M | 0.3% | — | — | — | 878972108 |
| RIGL | RIGEL PHARMACEUTICALS INC | 70,000 | $1.893M | 0.2% | — | — | — | 766559702 |
| NXTC | NEXTCURE INC | 141,181 | $1.508M | 0.1% | — | — | — | 65343E207 |
| — | PERSPECTIVE THERAPEUTICS INC | 200,000 | $834K | 0.1% | — | — | — | 46489V902 |
| PLX | PROTALIX BIOTHERAPEUTICS INC | 340,000 | $738K | 0.1% | — | — | — | 74365A309 |
| LBRX | LB PHARMACEUTICALS INC | 14,506 | $358K | 0.0% | — | — | — | 50180M108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORPORATION | 2,447,500 (-3.8%) | $195M (+119.7%) | 17.7% | — | — | COM NEW | 53635D202 |
| SNWV | SANUWAVE HEALTH INC | 306,140 (-68.8%) | $3.061M (-82.0%) | 0.3% | — | — | COM | 80303D305 |
| CGON | CG ONCOLOGY INC | 17,789 (-81.2%) | $1.264M (-80.3%) | 0.1% | — | — | COM | 156944100 |
| QTTB | Q32 BIO INC | 931,000 (-25.9%) | $11.86M (+47.1%) | 1.1% | — | — | COM | 746964105 |
| ANNX | ANNEXON INC | 1,714,451 (-26.5%) | $9.79M (-24.2%) | 0.9% | — | — | COM | 03589W102 |
| JBIO | JADE BIOSCIENCES INC | 145,000 (-66.1%) | $3.222M (-46.4%) | 0.3% | — | — | COM NEW | 008064206 |
| HROW | HARROW INC | 2,400,000 (-15.3%) | $102M (+2.1%) | 9.2% | — | — | COM | 415858109 |
| DERM | JOURNEY MED CORP | 350,000 (-63.5%) | $2.478M (-45.0%) | 0.2% | — | — | COM | 48115J109 |
| TRVI | TREVI THERAPEUTICS INC | 310,000 (-10.2%) | $5.782M (+40.4%) | 0.5% | — | — | COM | 89532M101 |
| AVIR | ATEA PHARMACEUTICALS INC | 235,000 (-27.2%) | $1.093M (-37.0%) | 0.1% | — | — | COM | 04683R106 |
| BDSX | BIODESIX INC | 180,000 (-24.4%) | $4.059M (+17.6%) | 0.4% | — | — | COM | 09075X207 |
| FBIO | FORTRESS BIOTECH INC | 890,000 (-14.6%) | $2.723M (-6.3%) | 0.2% | — | — | COM NEW | 34960Q307 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ETON | ETON PHARMACEUTICALS INC | 2,860,000 | $104M | 9.4% | — | — | COM | 29772L108 |
| URGN | UROGEN PHARMA LTD | 1,439,996 | $52.99M | 4.8% | — | — | COM | M96088105 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 122,500 | $13.6M | 1.2% | — | — | COM | 76243J105 |
| APGE | APOGEE THERAPEUTICS INC | 390,000 | $51.76M | 4.7% | — | — | COM | 03770N101 |
| RZLT | REZOLUTE INC | 6,300,000 | $32.76M | 3.0% | — | — | COM NEW | 76200L309 |
| TGTX | TG THERAPEUTICS INC | 535,000 | $29.39M | 2.7% | — | — | COM | 88322Q108 |
| RVMD | REVOLUTION MEDICINES INC | 100,000 | $18.73M | 1.7% | — | — | COM | 76155X100 |
| MBX | MBX BIOSCIENCES INC | 260,000 | $14.35M | 1.3% | — | — | COM | 55287L101 |
| EWTX | EDGEWISE THERAPEUTICS INC | 500,000 | $20.32M | 1.8% | — | — | COM | 28036F105 |
| CDXS | CODEXIS INC | 6,785,000 | $15.33M | 1.4% | — | — | COM | 192005106 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 1,412,656 | $6.851M | 0.6% | — | — | COM | 98943L107 |
| ALMS | ALUMIS INC | 550,000 | $15.48M | 1.4% | — | — | COM | 022307102 |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 500,000 | $37.07M | 3.4% | — | — | SHS NEW | M8694L137 |
| IRD | OPUS GENETICS INC | 1,125,000 | $4.624M | 0.4% | — | — | COM | 67577R102 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 100,000 | $12.26M | 1.1% | — | — | COM | 74366E102 |
| OCUL | OCULAR THERAPEUTIX INC | 600,000 | $5.892M | 0.5% | — | — | COM | 67576A100 |
| CBIO | CRESCENT BIOPHARMA INC. | 1,319,351 | $23.75M | 2.2% | — | — | COM | G2545C104 |
| ENTA | ENANTA PHARMACEUTICALS INC | 125,000 | $1.823M | 0.2% | — | — | COM | 29251M106 |
| STOK | STOKE THERAPEUTICS INC | 700,000 | $22.9M | 2.1% | — | — | COM | 86150R107 |
| RLMD | RELMADA THERAPEUTICS INC | 935,000 | $6.47M | 0.6% | — | — | COM | 75955J402 |
| ADGM | ADAGIO MED HLDGS INC | 18,444 | $13,353 | 0.0% | — | — | COM | 00534B100 |